Quantum dots as a platform for nanoparticle drug delivery vehicle design

Abstract

Nanoparticle-based drug delivery (NDD) has emerged as a promising approach to improving upon the efficacy of existing drugs and enabling the development of new therapies. Proof-of-concept studies have demonstrated the potential for NDD systems to simultaneously achieve reduced drug toxicity, improved bio-availability, increased circulation times, controlled drug release, and targeting. However, clinical translation of NDD vehicles with the goal of treating particularly challenging diseases, such as cancer, will require a thorough understanding of how nanoparticle properties influence their fate in biological systems, especially in vivo. Consequently, a model system for systematic evaluation of all stages of NDD with high sensitivity, high resolution, and low cost is highly desirable. In theory, this system should maintain the properties and behavior of the original NDD vehicle, while providing mechanisms for monitoring intracellular and systemic nanocarrier distribution, degradation, drug release, and clearance. For such a model system, quantum dots (QDots) offer great potential. QDots feature small size and versatile surface chemistry, allowing their incorporation within virtually any NDD vehicle with minimal effect on overall characteristics, and offer superb optical properties for real-time monitoring of NDD vehicle transport and drug release at both cellular and systemic levels. Though the direct use of QDots for drug delivery remains questionable due to their potential long-term toxicity, the QDot core can be easily replaced with other organic drug carriers or more biocompatible inorganic contrast agents (such as gold and magnetic nanoparticles) by their similar size and surface properties, facilitating translation of well characterized NDD vehicles to the clinic, maintaining NDD imaging capabilities, and potentially providing additional therapeutic functionalities such as photothermal therapy and magneto-transfection. In this review we outline unique features that make QDots an ideal platform for nanocarrier design and discuss how this model has been applied to study NDD vehicle behavior for diverse drug delivery applications.

Untitled

“…Recently, Karthik et al developed fluorescent GCDs tethered to a quinoline based phototrigger for regulated delivery of anticancer drugs. 53 The decorated CNDs can enter the cytoplasm, as well as nucleus of cells, and loaded drug can be released using both one-photon and two-photon excitation.…”

Controlled nitric oxide release for tissue repair and regeneration

“…It is absolutely vital to deliver NO to the target area in a well-contained manner, for excessive amounts of NO could pose a greater risk of injury to certain tissues. Nanoparticle-based drug delivery systems have been broadly used as a promising method to improve the efficacy of existing drugs with the ability to achieve increased therapeutic duration, enhanced bioavailability, and controlled drug release (Probst et al, 2013). Conjugating NO donors to nanoparticles (NONPs) could significantly increase the therapeutic effect of NO.…”

A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment

“…Most drugs used in conventional therapeutic strategies have low solubility, high metabolism and are hydrophobic, making them biologically unavailable leading to systemic toxicity. 5 The development of nanomedicine increases the possibility of specific targeted delivery, which overcomes tumor barriers. It is expected to better facilitate drug delivery and increase efficacy while minimizing the side effects of anticancer drugs.…”